Beyaz 28 Day Pack
- RxCUI
- 1013630
- RxNorm name
- Beyaz 28 Day Pack
- Display name
- Beyaz 28 Day Pack
- Full name
- Beyaz 28 Day Pack
- Term type
- SY
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:06
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Beyaz | DROSPIRENONE/ETHINYL ESTRADIOL/LEVOMEFOLATE CALCIUM AND LEVOMEFOLATE CALCIUM | Bayer HealthCare Pharmaceuticals Inc. | 8132454a-6135-4bac-b206-83a55eb8dbc6 | 2026-03-02 | Boxed warning, Warnings, Adverse reactions | 1013630 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm string | TTY | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 8132454a-6135-4bac-b206-83a55eb8dbc6 | Beyaz 28 Day Pack | SY | 23 | These highlights do not include all the information needed to use BEYAZ safely and effectively. See full prescribing information for BEYAZ. BEYAZ (drospirenone/ethinyl estradiol/levomefolate calcium tablets and levomefolate calcium tablets), for oral use Initial U.S. Approval: 2010 | 20260302 |
| 8132454a-6135-4bac-b206-83a55eb8dbc6 | {24 (drospirenone 3 MG / ethinyl estradiol 0.02 MG / levomefolate calcium 0.451 MG Oral Tablet) / 4 (levomefolate calcium 0.451 MG Oral Tablet) } Pack [Beyaz 28 Day] | BPCK | 23 | These highlights do not include all the information needed to use BEYAZ safely and effectively. See full prescribing information for BEYAZ. BEYAZ (drospirenone/ethinyl estradiol/levomefolate calcium tablets and levomefolate calcium tablets), for oral use Initial U.S. Approval: 2010 | 20260302 |
| 8132454a-6135-4bac-b206-83a55eb8dbc6 | Beyaz 28 Day Pack | PSN | 23 | These highlights do not include all the information needed to use BEYAZ safely and effectively. See full prescribing information for BEYAZ. BEYAZ (drospirenone/ethinyl estradiol/levomefolate calcium tablets and levomefolate calcium tablets), for oral use Initial U.S. Approval: 2010 | 20260302 |